5% STAKE4884.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Kringle Pharma to 15.35%

Stake history

14%16%18%20%22%19.60%Aug 8Aug 8: 19.60% · S100WHGR18.91%Aug 22Aug 22: 18.91% · S100WKRA18.24%Sep 24Sep 24: 18.24% · S100WQ7A17.27%Oct 15Oct 15: 17.27% · S100WULJ17.23%Oct 16Oct 16: 17.23% · S100WVGD16.21%Dec 3Dec 3: 16.21% · S100X7ZO15.35%Mar 18Mar 18: 15.35% · S100XRCM
14%16%18%20%22%19.60%Aug 8Aug 8: 19.60% · S100WHGR18.91%Aug 22Aug 22: 18.91% · S100WKRA18.24%Sep 24Sep 24: 18.24% · S100WQ7A17.27%Oct 15Oct 15: 17.27% · S100WULJ17.23%Oct 16Oct 16: 17.23% · S100WVGD16.21%Dec 3Dec 3: 16.21% · S100X7ZO15.35%Mar 18Mar 18: 15.35% · S100XRCM

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-03-18 11:16 JST concerning Kringle Pharma, Inc. Reported holding ratio: 15.35%, previous report: 16.21%.

Open the price chart on TradingView.

Source: EDINET S100XRCM ↗ · PDL1.0 · Not investment advice